Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaojian Han

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Current Research in Translational Medicine|May 4, 2025
Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insightsChangchang Sun, Mingli Xu, Min Yan, et al.
Journal of Cancer|September 14, 2017
Identification of Novel Epitopes with Agonistic Activity for the Development of Tumor Immunotherapy Targeting TRAIL-R1Lu Guo, Xin Sun, Zhichao Hao, et al.
Annals of Medicine|October 4, 2022
Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapyDan Shu, Meiying Shen, Kang Li, et al.
Biochemical and Biophysical Research Communications|July 29, 2021
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 sheddingYingyi Long, Shuyi Song, Feiyang Luo, et al.
International Immunopharmacology|June 14, 2021
p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-βSiyin Chen, Jing Zhang, Meiying Shen, et al.
Biochemical and Biophysical Research Communications|May 22, 2016
Fully human monoclonal antibodies to TRAIL-R1 enhance TRAIL-induced apoptosis via activation of caspase-8 pathwayZhichao Hao, Xiaojian Han, Xin Sun, et al.
Journal of Translational Medicine|January 17, 2025
Identification of novel KRAS<sup>G12D</sup> neoantigen specific TCRs and a strategy to eliminate off-target recognitionXiaojian Han, Xiaxia Han, Yanan Hao, et al.
Frontiers in Cell and Developmental Biology|November 22, 2021
T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent PatientsLuo Li, Qian Chen, Xiaojian Han, et al.
Journal for Immunotherapy of Cancer|July 18, 2025
Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRAS<sup>G12V</sup> neoantigen without cross-recognition of the self-antigen RAB7B in solid tumorsMeiying Shen, Yanan Hao, Xiaxia Han, et al.
Journal of Translational Medicine|July 31, 2024
Targeting tumor-infiltrating CCR8<sup>+</sup> regulatory T cells induces antitumor immunity through functional restoration of CD4<sup>+</sup> T<sub>convs</sub> and CD8<sup>+</sup> T cells in colorectal cancerQian Chen, Meiying Shen, Min Yan, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Current Research in Translational Medicine|May 4, 2025
Multidimensional evaluation of CMV-specific T Cells: enhancing therapy through transcriptional insightsChangchang Sun, Mingli Xu, Min Yan, et al.
Journal of Cancer|September 14, 2017
Identification of Novel Epitopes with Agonistic Activity for the Development of Tumor Immunotherapy Targeting TRAIL-R1Lu Guo, Xin Sun, Zhichao Hao, et al.
Annals of Medicine|October 4, 2022
Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapyDan Shu, Meiying Shen, Kang Li, et al.
Biochemical and Biophysical Research Communications|July 29, 2021
A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 sheddingYingyi Long, Shuyi Song, Feiyang Luo, et al.
International Immunopharmacology|June 14, 2021
p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-βSiyin Chen, Jing Zhang, Meiying Shen, et al.
Biochemical and Biophysical Research Communications|May 22, 2016
Fully human monoclonal antibodies to TRAIL-R1 enhance TRAIL-induced apoptosis via activation of caspase-8 pathwayZhichao Hao, Xiaojian Han, Xin Sun, et al.
Journal of Translational Medicine|January 17, 2025
Identification of novel KRAS<sup>G12D</sup> neoantigen specific TCRs and a strategy to eliminate off-target recognitionXiaojian Han, Xiaxia Han, Yanan Hao, et al.
Frontiers in Cell and Developmental Biology|November 22, 2021
T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent PatientsLuo Li, Qian Chen, Xiaojian Han, et al.
Journal for Immunotherapy of Cancer|July 18, 2025
Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRAS<sup>G12V</sup> neoantigen without cross-recognition of the self-antigen RAB7B in solid tumorsMeiying Shen, Yanan Hao, Xiaxia Han, et al.
Journal of Translational Medicine|July 31, 2024
Targeting tumor-infiltrating CCR8<sup>+</sup> regulatory T cells induces antitumor immunity through functional restoration of CD4<sup>+</sup> T<sub>convs</sub> and CD8<sup>+</sup> T cells in colorectal cancerQian Chen, Meiying Shen, Min Yan, et al.
Pageof 3